FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16699011000001102: Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Apr 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58689601000001114 Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58689701000001116 Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Is a Mifamurtide 4mg powder for suspension for infusion vials true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has specific active ingredient Mifamurtide false Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has dispensed dose form Powder for suspension for infusion false Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Is a Mepact true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has specific active ingredient Mifamurtide true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has manufactured dose form Powder for suspension for infusion false Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has manufactured dose form Powder for suspension for infusion true Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has dispensed dose form Powder for suspension for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) 1 vial Has AMP True Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start